These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30123968)

  • 21. Dose-dependent bronchospasm from sulfites in isoetharine.
    Koepke JW; Christopher KL; Chai H; Selner JC
    JAMA; 1984 Jun; 251(22):2982-3. PubMed ID: 6716626
    [No Abstract]   [Full Text] [Related]  

  • 22. Contact allergy to sodium sulfite and its relationship to sodium metabisulfite.
    Oliphant T; Mitra A; Wilkinson M
    Contact Dermatitis; 2012 Mar; 66(3):128-30. PubMed ID: 22320666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of cutaneous delayed-type allergy to oral dexamethasone and to betamethasone.
    Nucera E; Buonomo A; Pollastrini E; De Pasquale T; Del Ninno M; Roncallo C; Schiavino D; Patriarca G
    Dermatology; 2002; 204(3):248-50. PubMed ID: 12037457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of apomorphine in clinical practice.
    MacMahon DG
    Adv Neurol; 1999; 80():529-33. PubMed ID: 10410767
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug eruption following high-calorie infusion: a possible systemic type IV allergic reaction to sulphites.
    Honda T; Kitoh A; Miyachi Y; Kabashima K
    Acta Derm Venereol; 2015 Sep; 95(7):854-5. PubMed ID: 25783746
    [No Abstract]   [Full Text] [Related]  

  • 26. [Survey of pathologies caused by sulfites in allergology].
    Hassoun S; Bonneau JC; Drouet M; Sabbah A
    Allerg Immunol (Paris); 1994 May; 26(5):184, 187-8. PubMed ID: 8086106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ubiquitous sulfites.
    Sogn D
    JAMA; 1984 Jun; 251(22):2986-7. PubMed ID: 6716628
    [No Abstract]   [Full Text] [Related]  

  • 28. Differential diagnosis of late-type reactions to injected local anaesthetics: Inflammation at the injection site is the only indicator of allergic hypersensitivity.
    Trautmann A; Stoevesandt J
    Contact Dermatitis; 2019 Feb; 80(2):118-124. PubMed ID: 30311217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apomorphine infusion in advanced Parkinson disease.
    Antonini A; Jenner P
    Nat Rev Neurol; 2018 Dec; 14(12):693-694. PubMed ID: 30279608
    [No Abstract]   [Full Text] [Related]  

  • 30. A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease.
    Chen JJ; Obering C
    Clin Ther; 2005 Nov; 27(11):1710-24. PubMed ID: 16368444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delayed-type hypersensitivity after subcutaneous administration of amide anesthetic.
    Whalen JD; Dufresne RG
    Arch Dermatol; 1996 Oct; 132(10):1256-7. PubMed ID: 8859051
    [No Abstract]   [Full Text] [Related]  

  • 32. Systemic delayed hypersensitivity reaction to chlorambucil: a case report and literature review.
    Bianchi L; Hansel K; Pelliccia S; Tramontana M; Stingeni L
    Contact Dermatitis; 2018 Feb; 78(2):171-173. PubMed ID: 29341183
    [No Abstract]   [Full Text] [Related]  

  • 33. Apomorphine can sustain the long-duration response to L-DOPA in fluctuating PD.
    Nutt JG; Carter JH
    Neurology; 2000 Jan; 54(1):247-50. PubMed ID: 10636162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse reactions to sulfites.
    Yang WH; Purchase EC
    CMAJ; 1985 Nov; 133(9):865-7, 880. PubMed ID: 4052897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Severe complications related to metabisulfites].
    Maria Y; Vaillant P; Delorme N; Moneret-Vautrin DA
    Rev Med Interne; 1989; 10(1):36-40. PubMed ID: 2717827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DA agonists -- non-ergot derivatives: apomorphine: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S83-9. PubMed ID: 12211146
    [No Abstract]   [Full Text] [Related]  

  • 37. Local anesthetic intolerance due to metabisulfite.
    Dooms-Goossens A; de Alam AG; Degreef H; Kochuyt A
    Contact Dermatitis; 1989 Feb; 20(2):124-6. PubMed ID: 2706960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed hypersensitivity to flurbiprofen.
    Romano A; Pietrantonio F
    J Intern Med; 1997 Jan; 241(1):81-3. PubMed ID: 9042097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Candidate patient for treatment with continuous apomorphine infusion].
    Martí MJ; Kulisevsky J
    Rev Neurol; 2012; 55 Suppl 1():S15-9. PubMed ID: 23169228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions.
    Hassoun-Kheir N; Bergman R; Weltfriend S
    Int J Dermatol; 2016 Nov; 55(11):1219-1224. PubMed ID: 27368159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.